Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Banner Beats Biogen On Tecfidera Technicality

Hybrid 505(b)(2) Product Holds Tentative US Approval

21 Apr 2020

• By Dean Rudge

Gavels — A US Court Appeals has ruled in favor of Banner Life Sciences • Source: Shutterstock

Related Content

Biogen Vumerity Receives Full US Approval, But GI Comparison With Tecfidera Must Wait

31 Oct 2019

Biogen's Tecfidera Safe Following IPR Decision – For Now

06 Feb 2020

Related Companies

Biogen, Inc.

Additional Topics

United States Intellectual Property Legal Issues BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.